Prognostic prediction in patients with metastatic renal cell carcinoma treated with sorafenib based on expression levels of potential molecular markers in radical nephrectomy specimens.

Kusuda, Yuji

Prognostic prediction in patients with metastatic renal cell carcinoma treated with sorafenib based on expression levels of potential molecular markers in radical nephrectomy specimens. [electronic resource] - Urologic oncology Jan 2013 - 42-50 p. digital

Publication Type: Journal Article

1873-2496

10.1016/j.urolonc.2010.09.008 doi


Adult
Aged
Aged, 80 and over
Antineoplastic Agents--therapeutic use
Biomarkers, Tumor--metabolism
Bone Neoplasms--metabolism
Carcinoma, Renal Cell--metabolism
Combined Modality Therapy
Disease Progression
Female
Follow-Up Studies
Humans
Immunoenzyme Techniques
Kidney Neoplasms--metabolism
Male
Middle Aged
Neoplasm Grading
Neoplasm Metastasis
Neoplasm Staging
Nephrectomy--mortality
Niacinamide--analogs & derivatives
Phenylurea Compounds--therapeutic use
Prognosis
Sorafenib
Survival Rate